IL130160A0 - Inactivation of HIV co-receptors as therapy for HIV infection - Google Patents

Inactivation of HIV co-receptors as therapy for HIV infection

Info

Publication number
IL130160A0
IL130160A0 IL13016097A IL13016097A IL130160A0 IL 130160 A0 IL130160 A0 IL 130160A0 IL 13016097 A IL13016097 A IL 13016097A IL 13016097 A IL13016097 A IL 13016097A IL 130160 A0 IL130160 A0 IL 130160A0
Authority
IL
Israel
Prior art keywords
hiv
inactivation
receptors
therapy
infection
Prior art date
Application number
IL13016097A
Original Assignee
Univ Wake Forest
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wake Forest filed Critical Univ Wake Forest
Publication of IL130160A0 publication Critical patent/IL130160A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
IL13016097A 1996-12-02 1997-12-02 Inactivation of HIV co-receptors as therapy for HIV infection IL130160A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3227796P 1996-12-02 1996-12-02
PCT/US1997/022198 WO1998024923A1 (en) 1996-12-02 1997-12-02 Inactivation of hiv co-receptors as therapy for hiv infection

Publications (1)

Publication Number Publication Date
IL130160A0 true IL130160A0 (en) 2000-06-01

Family

ID=21864069

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13016097A IL130160A0 (en) 1996-12-02 1997-12-02 Inactivation of HIV co-receptors as therapy for HIV infection
IL130160A IL130160A (en) 1996-12-02 1999-05-27 Expression vector for blocking hiv entry into a cell and compositions comprising cells transduced with such vector

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL130160A IL130160A (en) 1996-12-02 1999-05-27 Expression vector for blocking hiv entry into a cell and compositions comprising cells transduced with such vector

Country Status (6)

Country Link
EP (1) EP0963441A4 (en)
JP (1) JP2001505055A (en)
AU (1) AU721121B2 (en)
CA (1) CA2273192A1 (en)
IL (2) IL130160A0 (en)
WO (1) WO1998024923A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030049251A1 (en) * 1999-12-08 2003-03-13 Barbas Carlos F. Methods and compositions useful for inhibiting ccr5-dependent infection of cells by hiv-1
CN100480260C (en) 2002-07-18 2009-04-22 克鲁塞尔荷兰公司 Recombinant production of mixtures of antibodies
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
WO2004106375A1 (en) 2003-05-30 2004-12-09 Merus Biopharmaceuticals B.V. I.O. Fab library for the preparation of anti vegf and anti rabies virus fabs
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
NZ772318A (en) 2012-04-20 2023-06-30 Merus Nv Methods and means for the production of ig-like molecules

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE202145T1 (en) * 1994-11-01 2001-06-15 Winfried Wels NUCLEIC ACID DELIVERY SYSTEM
DE69729389D1 (en) * 1996-11-06 2004-07-08 Nasa PROTEASE ACTIVATED PSEUDOMONAS EXOTOXIN-A-LIKE PROPROTEINS
US6100387A (en) * 1997-02-28 2000-08-08 Genetics Institute, Inc. Chimeric polypeptides containing chemokine domains
US6214540B1 (en) * 1997-03-26 2001-04-10 University Of Maryland Biotechnology Institute Chemokines that inhibit immunodeficiency virus infection and methods based thereon
GB9718609D0 (en) * 1997-09-02 1997-11-05 Imp College Innovations Ltd Fusion protein
MXPA00003885A (en) * 1997-10-22 2004-04-23 Inst Genetics Llc Chimeric polypeptides containing chemokine domains.
US6110695A (en) * 1997-12-02 2000-08-29 The Regents Of The University Of California Modulating the interaction of the chemokine, B Lymphocyte Hemoattractant, and its Receptor, BLR1

Also Published As

Publication number Publication date
JP2001505055A (en) 2001-04-17
AU721121B2 (en) 2000-06-22
CA2273192A1 (en) 1998-06-11
AU5372498A (en) 1998-06-29
EP0963441A4 (en) 2002-10-02
WO1998024923A1 (en) 1998-06-11
IL130160A (en) 2007-07-04
EP0963441A1 (en) 1999-12-15

Similar Documents

Publication Publication Date Title
ZA944488B (en) System for viral inactivation of blood
ZA954436B (en) Process of sterilization
ZA906621B (en) Use of viruses against undesirable micro-organisms
AU7973994A (en) Combination therapy for hiv infection
AUPM761094A0 (en) Treatment of hides
AU5157998A (en) Methods and compositions for treatment of hepatitis c infection
AU3474593A (en) Hypericin treatment of vaccine agents for improved immunogenicity
IL130160A0 (en) Inactivation of HIV co-receptors as therapy for HIV infection
AU7717396A (en) Inactivation of pathogens using hydroxymethylamines
HRP960045B1 (en) Combination therapy for hiv infection
AU4602897A (en) Method for treatment of immunodeficiency virus infection
HU9603567D0 (en) Combination therapy for hiv infection
AU3530395A (en) Treatment of viral infections
HUP0100365A3 (en) Combination therapy for the treatment of aids
AU4604697A (en) Compositions and methods for the treatment of human cytomegalovirus infection
GB9317943D0 (en) Treatment of laminitis
AU1389897A (en) Use of chemokines for the treatment and prevention of hiv infection
GB9508300D0 (en) HIV protease inhibtors for the treatment of aids
AU5419894A (en) Dental treatment aid
AU1979397A (en) Peptidomimetics for the treatment of hiv infection
AU4219799A (en) Combination therapy for treatment of fiv infection
AU3638895A (en) Heat treatment for viral inactivation
AU2732297A (en) Benzamide treatment of dementia associated with aids virus (hiv-1) infection
ZA956662B (en) Combination therapy for HIV infection
GB9625123D0 (en) Treatment of cotton

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed